Medical ablation involves removal of a part of biological tissue or aberrant tissue from within the body via minimally invasive procedures, usually by using percutaneous chemical ablation, radiofrequency ablation, irreversible electroporation, cryoablation, microwave ablation, high-intensity–focused ultrasound ablation equipment.
The global ablation technologies market report estimates the market size (Revenue US$ million – 2014 to 2021) for key market segments based on type of technologies or equipment used (cryoablation, electric, light or laser, microwave, radiofrequency, and ultrasound) and applications (cardiovascular, gynecology, oncology, ophthalmology, pain management, and urology) and forecasts growth trends (CAGR% – 2017 to 2021).
By technology, the radiofrequency (RF) segment holds the major market share global ablation technologies market due to its high success rate, wide range of approved applications and low complications. The cardiology and oncology application segment recorded the highest market revenue and it is likely continue its dominance in the global ablation technologies market during the forecast period. Cryotherapy and ultrasound technologies are the upcoming technologies with new applications introduced by many companies through extensive research and development activities.
The global ablation technologies market segmentation is based on geography (regional and country based). The global ablation technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global ablation technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players profiled in this report include Angiodynamics, Inc., Biosense Webster Inc., Boston Scientific Corporation, AtriCure, Inc., Medtronic, BSD Medical Corporation, and St. Jude Medical Inc.